Moderna's (NASDAQ:MRNA) mRNA-1647, its vaccine asset for cytomegalovirus (CMV), may not yield positive interim phase 3 data ...

Leerink analyst warned that Moderna (NASDAQ:MRNA) shares could fall more than 30% if interim results from its Phase 3 CMV ...

Leerink Partners的分析师基于研究入组完成的时间和最近管理层在伦敦竞争对手会议上的评论，突出了一些担忧。这些担忧与更广泛的市场情绪一致， InvestingPro ...

Fleet Readiness Center East has announced it set a new record by inducting its first Navy CMV-22B Osprey on August 21. This comes after the station had expanded its service capabilities to include ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

INDIANAPOLIS (WISH) — The National CMV Foundation will be represented at the 2024 TCS New York City Marathon on Sunday. The foundation aims to raise awareness for a virus — cytomegalovirus ...

Hemoglobin levels are associated with seropositivity to cytomegalovirus (CMV) in patients with end-stage renal disease (ESRD), according to Michiel Betjes and colleagues at the Erasmus Medical ...

Infections and reactions to medications are two common causes of petechiae. Cytomegalovirus (CMV) CMV is an illness caused by a virus. Other symptoms include fatigue, fever, sore throat ...

Takeda has scored the first-ever FDA approval of a treatment for refractory cytomegalovirus (CMV) infections in organ transplant patients, which can lead to an increased risk of complications and ...

BioViva is building a gene-therapy platform using a cytomegalovirus (CMV) that can carry a genetic payload three times larger than the AAV. The company hopes to expand this to at least 10 times ...